JAGX is the official stock exchange ticker symbol for Jaguar Health, Inc., a commercial-stage pharmaceuticals enterprise focused on developing novel, plant-based non-opioid gastrointestinal medicines for human and animal health applications. The company utilizes active compounds derived from rainforest medicinal plants to target rare diseases, congenital disorders, and various forms of chronic diarrhea, with its common shares listed publicly on the Nasdaq capital market.